US FDA declines to approve Regenxbio's rare disease drug
US FDA declines to approve Regenxbio's rare disease drug
ReutersMon, February 9, 2026 at 9:13 PM UTC
0
A U.S. Food and Drug Administration (FDA) logo, a syringe and a vial are seen in this illustration taken May 13, 2025. REUTERS/Dado Ruvic/Illustration
Feb 9 (Reuters) - Regenxbio said on Monday the U.S. Food and Drug Administration has declined to approve its drug for a rare disease.
Advertisement
(Reporting by Sneha S K; Editing by Alan Barona)
Source: “AOL Breaking”
